FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4. (2019)

First Author: McClements L
Attributed to:  Confidence in Concept 2012 - Queen's University Belfast funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12885-019-5500-0

PubMed Identifier: 30975104

Publication URI: http://europepmc.org/abstract/MED/30975104

Type: Journal Article/Review

Volume: 19

Parent Publication: BMC cancer

Issue: 1

ISSN: 1471-2407